Isavuconazonium Sulfate Patent Expiration
Isavuconazonium Sulfate was first introduced by Astellas Pharma Us Inc
Isavuconazonium Sulfate Patents
Given below is the list of patents protecting Isavuconazonium Sulfate, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Cresemba | US10206879 | Active ingredient containing stabilised solid forms and method for the production thereof | Sep 14, 2027 | Astellas |
| Cresemba |
US10206879 (Pediatric) | Active ingredient containing stabilised solid forms and method for the production thereof | Mar 14, 2028 | Astellas |
| Cresemba | US10603280 | Active ingredient containing stabilised solid medicinal forms and methods for the production thereof | Sep 14, 2027 | Astellas |
| Cresemba |
US10603280 (Pediatric) | Active ingredient containing stabilised solid medicinal forms and methods for the production thereof | Mar 14, 2028 | Astellas |
| Cresemba | US10812238 | Configurable reference signals | Oct 31, 2025 | Astellas |
| Cresemba | US6812238 | N-substituted carbamoyloxyalkyl-azolium derivatives | Oct 31, 2025 | Astellas |
| Cresemba |
US6812238 (Pediatric) | N-substituted carbamoyloxyalkyl-azolium derivatives | May 01, 2026 | Astellas |
| Cresemba | US7459561 | N-substituted carbamoyloxyalkyl-azolium derivatives |
Oct 31, 2020
(Expired) | Astellas |
Coming Soon
Patent Strength Analyzer
YesNo
Thank you for your response 🥳